jephson pharmacy limited Company Information
Company Number
03739830
Website
-Registered Address
17 david road, colnbrook, slough, SL3 0DB
Industry
Dispensing chemist in specialised stores
Telephone
01793731466
Next Accounts Due
December 2024
Group Structure
View All
Directors
Davinder Virdee3 Years
Shareholders
breakspear (ashford) limited 100%
jephson pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of JEPHSON PHARMACY LIMITED at £272.9k based on a Turnover of £926k and 0.29x industry multiple (adjusted for size and gross margin).
jephson pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of JEPHSON PHARMACY LIMITED at £411.2k based on an EBITDA of £93k and a 4.42x industry multiple (adjusted for size and gross margin).
jephson pharmacy limited Estimated Valuation
Pomanda estimates the enterprise value of JEPHSON PHARMACY LIMITED at £493.7k based on Net Assets of £772.7k and 0.64x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Jephson Pharmacy Limited Overview
Jephson Pharmacy Limited is a live company located in slough, SL3 0DB with a Companies House number of 03739830. It operates in the dispensing chemist in specialised stores sector, SIC Code 47730. Founded in March 1999, it's largest shareholder is breakspear (ashford) limited with a 100% stake. Jephson Pharmacy Limited is a mature, small sized company, Pomanda has estimated its turnover at £926k with declining growth in recent years.
Upgrade for unlimited company reports & a free credit check
Jephson Pharmacy Limited Health Check
Pomanda's financial health check has awarded Jephson Pharmacy Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs
4 Strong
3 Regular
5 Weak
Size
annual sales of £926k, make it smaller than the average company (£12m)
- Jephson Pharmacy Limited
£12m - Industry AVG
Growth
3 year (CAGR) sales growth of -21%, show it is growing at a slower rate (5.3%)
- Jephson Pharmacy Limited
5.3% - Industry AVG
Production
with a gross margin of 31.7%, this company has a comparable cost of product (31.7%)
- Jephson Pharmacy Limited
31.7% - Industry AVG
Profitability
an operating margin of 10% make it more profitable than the average company (3.4%)
- Jephson Pharmacy Limited
3.4% - Industry AVG
Employees
with 7 employees, this is below the industry average (81)
- Jephson Pharmacy Limited
81 - Industry AVG
Pay Structure
on an average salary of £22k, the company has an equivalent pay structure (£22k)
- Jephson Pharmacy Limited
£22k - Industry AVG
Efficiency
resulting in sales per employee of £132.3k, this is equally as efficient (£138.7k)
- Jephson Pharmacy Limited
£138.7k - Industry AVG
Debtor Days
it gets paid by customers after 17 days, this is earlier than average (30 days)
- Jephson Pharmacy Limited
30 days - Industry AVG
Creditor Days
its suppliers are paid after 185 days, this is slower than average (69 days)
- Jephson Pharmacy Limited
69 days - Industry AVG
Stock Days
it holds stock equivalent to 98 days, this is more than average (30 days)
- Jephson Pharmacy Limited
30 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 4 weeks, this is less cash available to meet short term requirements (15 weeks)
4 weeks - Jephson Pharmacy Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 46.3%, this is a lower level of debt than the average (61.6%)
46.3% - Jephson Pharmacy Limited
61.6% - Industry AVG
JEPHSON PHARMACY LIMITED financials
Jephson Pharmacy Limited's latest turnover from March 2023 is estimated at £926 thousand and the company has net assets of £772.7 thousand. According to their latest financial statements, we estimate that Jephson Pharmacy Limited has 7 employees and maintains cash reserves of £58.7 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | ||||||||||||||
Other Income Or Grants | ||||||||||||||
Cost Of Sales | ||||||||||||||
Gross Profit | ||||||||||||||
Admin Expenses | ||||||||||||||
Operating Profit | ||||||||||||||
Interest Payable | ||||||||||||||
Interest Receivable | ||||||||||||||
Pre-Tax Profit | ||||||||||||||
Tax | ||||||||||||||
Profit After Tax | ||||||||||||||
Dividends Paid | ||||||||||||||
Retained Profit | ||||||||||||||
Employee Costs | ||||||||||||||
Number Of Employees | 15 | 15 | 15 | 15 | 18 | 21 | ||||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 66,409 | 67,093 | 68,030 | 64,992 | 66,025 | 68,261 | 68,836 | 71,940 | 71,792 | 66,235 | 68,697 | 72,197 | 82,752 | 87,487 |
Intangible Assets | 0 | 0 | 0 | 13,230 | 35,730 | 58,230 | 80,730 | 103,230 | 125,730 | 148,230 | 170,730 | 193,230 | 215,730 | 238,230 |
Investments & Other | 0 | 0 | 5 | 5 | 5 | 275,002 | 275,000 | 275,000 | 275,000 | 275,000 | 275,000 | 275,000 | 275,000 | 0 |
Debtors (Due After 1 year) | 0 | 0 | 25,300 | 25,300 | 25,300 | 25,300 | 54,555 | 64,399 | 25,300 | 25,300 | 0 | 0 | 0 | 0 |
Total Fixed Assets | 66,409 | 67,093 | 93,335 | 103,527 | 127,060 | 426,793 | 479,121 | 514,569 | 497,822 | 514,765 | 514,427 | 540,427 | 573,482 | 325,717 |
Stock & work in progress | 170,440 | 150,280 | 168,485 | 172,397 | 172,397 | 107,553 | 133,154 | 116,710 | 124,242 | 107,839 | 104,334 | 114,431 | 116,730 | 116,856 |
Trade Debtors | 43,446 | 47,322 | 277,566 | 296,107 | 237,322 | 359,484 | 309,997 | 307,076 | 533,124 | 652,653 | 710,135 | 713,081 | 495,186 | 329,627 |
Group Debtors | 0 | 0 | 285,000 | 33,104 | 41,842 | 33,216 | 67,912 | 68,341 | 0 | 0 | 0 | 0 | 0 | 0 |
Misc Debtors | 1,100,822 | 686,477 | 309,760 | 529,775 | 189,708 | 34,953 | 64,326 | 51,870 | 0 | 0 | 12,323 | 5,611 | 4,934 | 0 |
Cash | 58,709 | 194,202 | 242,683 | 262,117 | 546,967 | 160,443 | 190,710 | 183,392 | 127,280 | 190,750 | 95,238 | 47,146 | 118,842 | 244,561 |
misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
total current assets | 1,373,417 | 1,078,281 | 1,283,494 | 1,293,500 | 1,188,236 | 695,649 | 766,099 | 727,389 | 784,646 | 951,242 | 922,030 | 880,269 | 735,692 | 691,044 |
total assets | 1,439,826 | 1,145,374 | 1,376,829 | 1,397,027 | 1,315,296 | 1,122,442 | 1,245,220 | 1,241,958 | 1,282,468 | 1,466,007 | 1,436,457 | 1,420,696 | 1,309,174 | 1,016,761 |
Bank overdraft | 0 | 0 | 0 | 17,913 | 17,393 | 16,887 | 16,138 | 15,879 | 0 | 0 | 0 | 0 | 0 | 0 |
Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Trade Creditors | 321,456 | 185,414 | 422,940 | 382,369 | 294,664 | 255,632 | 325,611 | 279,524 | 347,058 | 356,294 | 343,668 | 387,067 | 344,726 | 280,829 |
Group/Directors Accounts | 59,841 | 28,725 | 0 | 503 | 569 | 64,849 | 1,454 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other current liabilities | 285,861 | 237,710 | 68,700 | 80,212 | 96,689 | 116,658 | 158,222 | 132,775 | 0 | 0 | 0 | 0 | 0 | 0 |
total current liabilities | 667,158 | 451,849 | 491,640 | 480,997 | 409,315 | 454,026 | 501,425 | 428,178 | 347,058 | 356,294 | 343,668 | 387,067 | 344,726 | 280,829 |
loans | 0 | 0 | 0 | 84,185 | 101,938 | 119,211 | 136,585 | 152,595 | 101,992 | 119,370 | 136,225 | 152,635 | 168,446 | 0 |
hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 66,482 | 64,513 | 62,603 | 60,744 | 65,558 | 14,966 |
provisions | 0 | 0 | 0 | 0 | 2 | 364 | 417 | 939 | 789 | 586 | 844 | 2,538 | 3,290 | 4,000 |
total long term liabilities | 0 | 0 | 0 | 84,185 | 101,940 | 119,575 | 137,002 | 153,534 | 169,263 | 184,469 | 199,672 | 215,917 | 237,294 | 18,966 |
total liabilities | 667,158 | 451,849 | 491,640 | 565,182 | 511,255 | 573,601 | 638,427 | 581,712 | 516,321 | 540,763 | 543,340 | 602,984 | 582,020 | 299,795 |
net assets | 772,668 | 693,525 | 885,189 | 831,845 | 804,041 | 548,841 | 606,793 | 660,246 | 766,147 | 925,244 | 893,117 | 817,712 | 727,154 | 716,966 |
total shareholders funds | 772,668 | 693,525 | 885,189 | 831,845 | 804,041 | 548,841 | 606,793 | 660,246 | 766,147 | 925,244 | 893,117 | 817,712 | 727,154 | 716,966 |
Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2013 | Mar 2012 | Mar 2011 | Mar 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | ||||||||||||||
Operating Profit | ||||||||||||||
Depreciation | 684 | 937 | 1,287 | 1,033 | 2,236 | 2,948 | 3,461 | 4,202 | 3,089 | 3,895 | 11,293 | 10,555 | 12,438 | 12,401 |
Amortisation | 0 | 0 | 13,230 | 22,500 | 22,500 | 22,500 | 22,500 | 22,500 | 22,500 | 22,500 | 22,500 | 22,500 | 22,500 | 26,470 |
Tax | ||||||||||||||
Stock | 20,160 | -18,205 | -3,912 | 0 | 64,844 | -25,601 | 16,444 | -7,532 | 16,403 | 3,505 | -10,097 | -2,299 | -126 | 116,856 |
Debtors | 410,469 | -163,827 | 13,340 | 390,114 | 41,219 | -43,837 | 5,104 | -66,738 | -119,529 | -44,505 | 3,766 | 218,572 | 170,493 | 329,627 |
Creditors | 136,042 | -237,526 | 40,571 | 87,705 | 39,032 | -69,979 | 46,087 | -67,534 | -9,236 | 12,626 | -43,399 | 42,341 | 63,897 | 280,829 |
Accruals and Deferred Income | 48,151 | 169,010 | -11,512 | -16,477 | -19,969 | -41,564 | 25,447 | 132,775 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes & Provisions | 0 | 0 | 0 | -2 | -362 | -53 | -522 | 150 | 203 | -258 | -1,694 | -752 | -710 | 4,000 |
Cash flow from operations | ||||||||||||||
Investing Activities | ||||||||||||||
capital expenditure | ||||||||||||||
Change in Investments | 0 | -5 | 0 | 0 | -274,997 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 275,000 | 0 |
cash flow from investments | ||||||||||||||
Financing Activities | ||||||||||||||
Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Group/Directors Accounts | 31,116 | 28,725 | -503 | -66 | -64,280 | 63,395 | 1,454 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term loans | 0 | 0 | -84,185 | -17,753 | -17,273 | -17,374 | -16,010 | 50,603 | -17,378 | -16,855 | -16,410 | -15,811 | 168,446 | 0 |
Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -66,482 | 1,969 | 1,910 | 1,859 | -4,814 | 50,592 | 14,966 |
share issue | ||||||||||||||
interest | ||||||||||||||
cash flow from financing | ||||||||||||||
cash and cash equivalents | ||||||||||||||
cash | -135,493 | -48,481 | -19,434 | -284,850 | 386,524 | -30,267 | 7,318 | 56,112 | -63,470 | 95,512 | 48,092 | -71,696 | -125,719 | 244,561 |
overdraft | 0 | 0 | -17,913 | 520 | 506 | 749 | 259 | 15,879 | 0 | 0 | 0 | 0 | 0 | 0 |
change in cash | -135,493 | -48,481 | -1,521 | -285,370 | 386,018 | -31,016 | 7,059 | 40,233 | -63,470 | 95,512 | 48,092 | -71,696 | -125,719 | 244,561 |
jephson pharmacy limited Credit Report and Business Information
Jephson Pharmacy Limited Competitor Analysis
Perform a competitor analysis for jephson pharmacy limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in SL3 area or any other competitors across 12 key performance metrics.
jephson pharmacy limited Ownership
JEPHSON PHARMACY LIMITED group structure
Jephson Pharmacy Limited has 2 subsidiary companies.
Ultimate parent company
2 parents
JEPHSON PHARMACY LIMITED
03739830
2 subsidiaries
jephson pharmacy limited directors
Jephson Pharmacy Limited currently has 1 director, Mr Davinder Virdee serving since Jun 2021.
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Davinder Virdee | England | 59 years | Jun 2021 | - | Director |
P&L
March 2023turnover
926k
-19%
operating profit
92.3k
0%
gross margin
31.8%
-1.33%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
772.7k
+0.11%
total assets
1.4m
+0.26%
cash
58.7k
-0.7%
net assets
Total assets minus all liabilities
jephson pharmacy limited company details
company number
03739830
Type
Private limited with Share Capital
industry
47730 - Dispensing chemist in specialised stores
incorporation date
March 1999
age
25
incorporated
UK
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
last accounts submitted
March 2023
address
17 david road, colnbrook, slough, SL3 0DB
accountant
-
auditor
-
jephson pharmacy limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 4 charges/mortgages relating to jephson pharmacy limited. Currently there are 3 open charges and 1 have been satisfied in the past.
jephson pharmacy limited Companies House Filings - See Documents
date | description | view/download |
---|